PRESS RELEASE
MAY 16, 2011
The Waxman Foundation Announces Donor Recognition Awards
NEW YORK CITY—Each year, the Samuel Waxman Cancer Research Foundation holds its annual review in May, where funded investigators come from all over the world to present their research findings before our Scientific Advisory Board. The culmination of this two-day meeting is our Annual Scientific Symposium.
The Annual Scientific Symposium was held on Monday, May 16, from 5-7 p.m. at the Apella Event Space at Alexandria Center in New York City. Donors and board members were invited to hear a select group of our scientists share, in lay terms, about their work. It was an exciting time to meet the scientists and to hear how Waxman Foundation grants have furthered their research over the past year.
In addition to hearing about critical research developments, this year's event also included Donor Recognition Awards.
"As the Foundation celebrates its 35-year anniversary, we wanted to honor individuals who have played an integral role in furthering our mission," said Gwen Darien, the Executive Director of the Waxman Foundation.
"We honor this year's awardees for the passion they have poured into Foundation over the years and for their dedication and commitment to cancer research," added Samuel Waxman, M.D., the Scientific Director and Founder of the Waxman Foundation.
The award recipients included:
Abner and Mildred Levine — Distinguished Service Award.
Reuben Mark — Spirit of Collaboration Award
Alfred J. Seaman — Distinguished Service Award.
The Three Strohm Sisters Family Foundation — Foundation Partnership Award
Dena K. Weiner — Board Service Award
###
About the Samuel Waxman Cancer Research Foundation
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research, focusing on uncovering the causes of cancer and reprogramming cancer cells.
We dedicate ourselves to delivering tailored, minimally toxic treatments to patients. Our mission is to eradicate cancer by bridging the gap between lab science and the patient.
Through our collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the SWCRF has awarded more than $75 million to support the work of more than 175 researchers across the globe.
For more information, visit waxmancancer.org.
